1,657 results on '"Cimaz Rolando"'
Search Results
2. In vitro effects of etanercept on the development of different T cell subsets in patients with juvenile idiopathic arthritis
3. Usefulness of MRI in the follow-up of ERA-related sacroiliitis, and effectiveness of treatment with sulphasalazine
4. Emperipolesis and cell death in NOD2-related Blau Syndrome and Crohn’s disease
5. Increased percentages of calprotectin and TNF-Α double-positive monocytes in the acute phase of Kawasaki disease
6. Semiquantitative classification (SQC) and Oxford classifications predict poor renal outcome better than The International Study of Kidney Disease in Children (ISKDC) and Haas in patients with IgAV nephritis: a multicenter study
7. Monogenic forms of systemic lupus erythematosus: new insights into SLE pathogenesis
8. Childhood chronic anterior uveitis associated with vernal keratoconjunctivitis (VKC): successful treatment with topical tacrolimus. Case series
9. Joint contractures in the absence of inflammation may indicate mucopolysaccharidosis
10. Takayasu arteritis in children
11. Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial
12. Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases
13. Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study
14. Development and implementation of the AIDA International Registry for patients with Behçet’s disease
15. DNASE1L3 deficiency, new phenotypes, and evidence for a transient type I IFN signaling
16. Extensive Ethnic Variation and Linkage Disequilibrium at the FCGR2/3 Locus: Different Genetic Associations Revealed in Kawasaki Disease.
17. Type I Interferonopathies
18. Development and Implementation of the AIDA International Registry for Patients with Non-Infectious Uveitis
19. Development and Implementation of the AIDA International Registry for Patients with Non-Infectious Scleritis
20. Hyaluronic Acid Therapy in Hip OA Does Not Perform Equally in Osteoarthritis Secondary to Juvenile Idiopathic Arthritis When Compared to Primary Osteoarthritis: A 2-Year Preliminary Evaluation
21. Drug Treatment of Low Bone Mass and Other Bone Conditions in Pediatric Patients
22. How Should We Classify Kawasaki Disease?
23. Genetic Variants and Therapeutic Response to Anti–TNF-α Agents in Juvenile Idiopathic Arthritis: An Updated Systematic Review and Meta-analysis
24. Correction to: Semiquantitative classification (SQC) and Oxford classifications predict poor renal outcome better than The International Study of Kidney Disease in Children (ISKDC) and Haas in patients with IgAV nephritis: a multicenter study
25. Contribution of rare and predicted pathogenic gene variants to childhood-onset lupus: a large, genetic panel analysis of British and French cohorts
26. Anakinra for Treatment-Resistant Kawasaki Disease: Evidence from a Literature Review
27. Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease
28. A peptide-based anti-Adalimumab antibody assay to monitor immune response to biologics treatment in juvenile idiopathic arthritis and childhood chronic non-infectious uveitis
29. Juvenile idiopathic arthritis in Harlequin ichthyosis, a rare combination or the clinical spectrum of the disease? Report of a child treated with etanercept and review of the literature
30. Correction to: Juvenile idiopathic arthritis in Harlequin ichthyosis, a rare combination or the clinical spectrum of the disease? Report of a child treated with etanercept and review of the literature
31. Preliminary data on prednisone effectiveness in children with Sydenham chorea
32. Interleukin-1 Blockade in Systemic Juvenile Idiopathic Arthritis
33. Hyaluronic Acid Injections in the Treatment of Osteoarthritis Secondary to Primary Inflammatory Rheumatic Diseases: A Systematic Review and Qualitative Synthesis
34. Association of juvenile idiopathic arthritis and morphea: a case series
35. JAK inhibitors in refractory juvenile idiopathic arthritis-associated uveitis
36. Pathogenesis, Clinical Findings and Treatment Advances in Kawasaki Disease
37. Long Coronavirus Disease in Pediatric Rheumatology
38. Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate Criteria
39. Metabolic Bone Disease and Osteoporosis in Children
40. Targeting immune checkpoints in juvenile idiopathic arthritis: accumulating evidence
41. Artifactual Skin Lesions: A Trap for Rheumatologists
42. Sex Differences in Pediatric Rheumatology
43. Pediatric Antiphospholipid Syndrome: from Pathogenesis to Clinical Management
44. Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial
45. Childhood Uveitis
46. Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome
47. Usefulness of magnetic resonance enterography in detecting signs of sacroiliitis in young patients with inflammatory bowel disease
48. The Effect of Corrected Inflammation, Oxidative Stress and Endothelial Dysfunction on Fmd Levels in Patients with Selected Chronic Diseases: A Quasi-Experimental Study
49. COVID-19 and what pediatric rheumatologists should know: a review from a highly affected country
50. Defining the risk of first intravenous immunoglobulin unresponsiveness in non-Asian patients with Kawasaki disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.